Read up on our latest news

Featured Story

Mirvie Founders
Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complications
May 17, 2022
The company announced it raised $60 million in Series B funding led by Decheng Capital. BlackRock, Foresite Capital, General Catalyst, GV, Khosla Ventures, and Mayfield participated in the round. Olympic runner Allyson Felix, whose daughter was born eight weeks early due to preeclampsia complications, also invested in the round. The company has raised a total of $90 million to date.
Read more
Stst Logo
Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complications
May 17, 2022
The company announced it raised $60 million in Series B funding led by Decheng Capital. BlackRock, Foresite Capital, General Catalyst, GV, Khosla Ventures, and Mayfield participated in the round. Olympic runner Allyson Felix, whose daughter was born eight weeks early due to preeclampsia complications, also invested in the round. The company has raised a total of $90 million to date.
Read more
Mirvie Founders

Media Coverage

press logo
Mom, 32, had a life-threatening pregnancy complication. Doctors dismissed the signs for weeks
May 23, 2024
Mirvie is developing a test to predict preeclampsia risk by looking at changes in the blood. Better testing will help more people be diagnosed earlier and also could help experts develop better treatments for it.
Read more
press logo
Birthing mothers’ near-death experience rates are 100 times higher than maternal mortality—and we don’t even know exactly why
May 10, 2024
We need more support to create a world where every pregnancy is as healthy and as safe as possible.
Read more
press logo
Blood test maker Mirvie ushers in Preeclampsia Awareness Month with prevention toolkit
July 3, 2024
The “Preeclampsia Prevention is Possible” campaign website includes a collection of downloadable resources aimed mainly at helping clinicians better recognize the early signs of the condition and shape their care plans for high-risk patients.
Read more
press logo
Patients interested in learning about preeclampsia risk
March 27, 2024
The majority of childbearing-age people would value predictive testing for preeclampsia and report they would act on this information, according to a study in BMC Pregnancy and Childbirth.
Read more
press logo
The future of pregnancy health: prediction and prevention
March 27, 2024
If doctors had better tools to understand each pregnancy’s biology, they could then help moms and babies achieve better outcomes.
Read more
press logo
Research highlights strong demand for data on personalized risk of preeclampsia
March 19, 2024
New research from Mirvie highlights significant demand for predictive testing for pregnancy complications like preeclampsia.
Read more
press logo
Preeclampsia & other pregnancy complications: What women need to know
April 2, 2024
Dr. Alison Cowan of Mirvie shares the facts behind common pregnancy complications and how women can advocate for themselves during pregnancy.
Read more
press logo
Mirvie announces landmark study on pregnancy complications
November 16, 2023
The US pregnancy platform Mirvie has completed enrolment of its 10,000 person research study on pregnancy complications. The study seeks to understand how RNA messages found in expectant mothers’ blood can predict life-threatening pregnancy complications.
Read more
press logo
Dr. Alison Cowan and using diagnostics to save women in pregnancy
October 10, 2023
Mirvie is changing the game for moms through their use of RNA testing to diagnosis potential pregnancy complications like pre-eclampsia, pre-term birth, and gestational diabetes earlier.
Read more
press logo
Exceder Biotech Startups Podcast
October 23, 2023
Finding & Addressing Unmet Needs | The Maternal Health Crisis | Creating an Empathy-Focused Company Culture | Fundraising & Hitting Milestones in a Recession
Read more
mirvie logo
A personalized window
into pregnancy health.
650-741-6510
651 Gateway Boulevard, Suite 1200
South San Francisco, California 94080
References
Terms of Service
Privacy Policy
©2024 Mirvie, Inc. All rights reserved. This product is in development. It has not been cleared by the FDA and is not available for sale in the United States.